Peer Reviewed
Perspectives

Fracture risk reduction in glucocorticoid-induced osteoporosis

Weiwen Chen, Jacqueline Center
Abstract
Patients requiring more than three months of glucocorticoid therapy should be assessed with regards to their fracture risk. Calcium and vitamin D supplementation is recommended as preventive therapy for all patients taking glucocorticoids, and pharmacological intervention should also be considered.
Key Points
  • Glucocorticoids have many direct effects on bone cells ultimately leading to reduced formation and increased resorption.
  • Increased risk of fracture is seen at higher bone mineral densities in patients taking glucocorticoids than those not taking glucocorticoids.
  • Assessment of fracture risk should be considered in any patient taking glucocorticoids for more than three months.
  • The lowest effective dose of glucocorticoids for the shortest possible time should be used.
  • Lifestyle factors should be optimised and appropriate pharmacological intervention considered in people taking glucocorticoids.
Get full access
Subscribe for full access to all articles
Buy this article

Single article purchases are temporarily unavailable due to site maintenance.

If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.

Thank you for your patience and understanding.

Already a subscriber?